Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial (Q35598520)
Jump to navigation
Jump to search
scientific article published on 12 May 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial |
scientific article published on 12 May 2015 |
Statements
1 reference
Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial (English)
1 reference
Abiy Habtewold
1 reference
Wondwossen Amogne
1 reference
Getachew Aderaye
1 reference
Lars Lindquist
1 reference
Anders Sonnerborg
1 reference
Alemayhu Worku
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference